On the other hand, in some other types of cancer, such as ovarian cancer and RCC, low expression of SLAMF7 has been associated with poor prognosis (179), suggesting that SLAMF7 may play a role in suppressing tumor growth in these contexts. This evidence concerns the gene SLAMF7 and renal cell carcinoma.